Shi-feng Huang
Qingyuan, 511518, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term NIR-light-controlled sustained release of PDGF-BB microsphere alleviates osteoarthritis with a single dose via the PI3K/AKT/GSK-3β/SOX9 Axis.
Journal: International immunopharmacology
Published: March 30, 2025
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway.
Journal: Frontiers in cardiovascular medicine
Published: September 03, 2021
LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases.
Journal: Frontiers in pharmacology
Published: June 23, 2021
Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics.
Journal: Pharmacological research
Published: June 17, 2021
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis.
Journal: Frontiers in cardiovascular medicine
Published: April 20, 2021
LncRNA MALAT1 facilitated the progression of myocardial infarction by sponging miR-26b.
Journal: International journal of cardiology
Published: March 25, 2021
Blocking lncRNA H19/miR-194-5p/SIRT1 axis in cardiac myocyte is responsible for doxycycline inhibiting autophagy.
Journal: International journal of cardiology
Published: December 07, 2020
Suppression of the HIF-1α/NLRP3 pathway is responsible for miR-135b protecting cardiomyocytes from infarction.
Journal: International journal of cardiology
Published: October 30, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026